Back to search

Article

Tumor Resectability and Pathologic Response After Neoadjuvant Long-Course Chemoradiotherapy for Locally Advanced Rectal Cancer in a Resource-Limited Setting

2026-03-27

Abstract excerpt

<h4>Purpose</h4> In resource-limited settings, locally advanced rectal cancer (LARC) often presents at advanced stages. Long-course chemoradiotherapy (LCCRT) remains a cornerstone of neoadjuvant therapy, yet outcome data from such settings remain limited. This study assessed tumor resectability, pathologic response, and factors associated with resectability following neoadjuvant LCCRT at Ethiopia’s largest tertia...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
51198593-3515-50f4-89c4-162e524d2e7e
DOI
10.64898/2026.03.25.26349327
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor Resectability and Pathologic Response After Neoadjuvant Long-Course Chemoradiotherapy for Locally Advanced Rectal Cancer in a Resource-Limited SettingDOI 10.64898/2026.03.25.26349327
Extensive multimodal treatments with Total Neoadjuvant Therapy followed by Total Mesorectal Excision for locally advanced rectal cancer allows fit older patients to achieve good oncologic and functional outcomes. Real world data and proof of conceptSemantic proximity
Factors Affecting Survival Prognosis of Patients with Rectal Cancer After Neoadjuvant ChemoradiotherapySemantic proximity
Assessing the practice of Total Neoadjuvant Therapy for rectal cancer: an online survey among Radiation Oncology Departments in Germany and German-Speaking Regions of Austria and SwitzerlandSemantic proximity
Rare but Marvelous Efficacy of Neoadjuvant Chemotherapy for Adenocarcinoma of Rectum: A Case ReportSemantic proximity
Study Protocol of A Phase II Study to Evaluate Safety and Efficacy of Neo-adjuvant Pembrolizumab and Radiotherapy in Localized Rectal CancerSemantic proximity
Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancerSemantic proximity
Comparative Analysis of Clinical Outcomes Between Neoadjuvant Chemoimmunotherapy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Retrospective StudySemantic proximity
Total Neoadjuvant Therapy and Organ Preservation in Locally Advanced Rectal Cancer: A State-of-the-Art Systematic Review and Critical AppraisalSemantic proximity
Oncologic Outcomes of One-Team Transanal Versus Laparoscopic Total Mesorectal Excision for Mid and Low Rectal Cancer: A Propensity Score–Matched StudySemantic proximity
An Integrated Model of Pathological Complete Response and Postoperative CEA Predicts Survival and Benefit of Adjuvant Chemotherapy for Locally Advanced Rectal CancerSemantic proximity
Adjuvant chemotherapy for poor-responders to neoadjuvant therapy in locally advanced rectal cancer: does it improve the prognosis?Semantic proximity
Rectal cancer.Semantic proximity
Select a neighboring publication to make it the new centre.